17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions
- Autores
- Gambino, Y.P.; Maymó, J.L.; Pérez-Pérez, A.; Dueñas, J.L.; Sánchez-Margalet, V.; Calvo, J.C.; Varone, C.L.
- Año de publicación
- 2010
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc.
Fil:Gambino, Y.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Maymó, J.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Varone, C.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. - Fuente
- Biol. Reprod. 2010;83(1):42-51
- Materia
-
17beta-estradiol
Gene expression
Leptin
MAPK signal transduction pathway
Placenta
2 (2 amino 3 methoxyphenyl)chromone
estradiol
estrogen receptor
estrogen receptor alpha
fulvestrant
leptin
luciferase
mitogen activated protein kinase
phosphatidylinositol 3 kinase
wortmannin
estradiol
estrogen receptor alpha
estrogen receptor alpha, human
fulvestrant
leptin
mitogen activated protein kinase
phosphatidylinositol 3 kinase
protein kinase B
adipocyte
article
cancer cell culture
choriocarcinoma
concentration response
controlled study
embryo
enzyme inhibition
enzyme phosphorylation
explant
gene deletion
gene expression
human
human cell
human tissue
nidation
placenta
plasmid
pregnancy
priority journal
promoter region
reporter gene
signal transduction
transient transfection
trophoblast
Western blotting
analogs and derivatives
antagonists and inhibitors
female
in vitro study
metabolism
placenta
signal transduction
tumor cell line
Bovinae
Cell Line, Tumor
Estradiol
Estrogen Receptor alpha
Extracellular Signal-Regulated MAP Kinases
Female
Humans
In Vitro Techniques
Leptin
MAP Kinase Signaling System
Phosphatidylinositol 3-Kinases
Placenta
Pregnancy
Promoter Regions, Genetic
Proto-Oncogene Proteins c-akt
Receptor Cross-Talk - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/2.5/ar
- Repositorio
- Institución
- Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
- OAI Identificador
- paperaa:paper_00063363_v83_n1_p42_Gambino
Ver los metadatos del registro completo
id |
BDUBAFCEN_0a920b2cbf470c623b1b3f5402ef71a4 |
---|---|
oai_identifier_str |
paperaa:paper_00063363_v83_n1_p42_Gambino |
network_acronym_str |
BDUBAFCEN |
repository_id_str |
1896 |
network_name_str |
Biblioteca Digital (UBA-FCEN) |
spelling |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actionsGambino, Y.P.Maymó, J.L.Pérez-Pérez, A.Dueñas, J.L.Sánchez-Margalet, V.Calvo, J.C.Varone, C.L.17beta-estradiolGene expressionLeptinMAPK signal transduction pathwayPlacenta2 (2 amino 3 methoxyphenyl)chromoneestradiolestrogen receptorestrogen receptor alphafulvestrantleptinluciferasemitogen activated protein kinasephosphatidylinositol 3 kinasewortmanninestradiolestrogen receptor alphaestrogen receptor alpha, humanfulvestrantleptinmitogen activated protein kinasephosphatidylinositol 3 kinaseprotein kinase Badipocytearticlecancer cell culturechoriocarcinomaconcentration responsecontrolled studyembryoenzyme inhibitionenzyme phosphorylationexplantgene deletiongene expressionhumanhuman cellhuman tissuenidationplacentaplasmidpregnancypriority journalpromoter regionreporter genesignal transductiontransient transfectiontrophoblastWestern blottinganalogs and derivativesantagonists and inhibitorsfemalein vitro studymetabolismplacentasignal transductiontumor cell lineBovinaeCell Line, TumorEstradiolEstrogen Receptor alphaExtracellular Signal-Regulated MAP KinasesFemaleHumansIn Vitro TechniquesLeptinMAP Kinase Signaling SystemPhosphatidylinositol 3-KinasesPlacentaPregnancyPromoter Regions, GeneticProto-Oncogene Proteins c-aktReceptor Cross-TalkThe process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc.Fil:Gambino, Y.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Maymó, J.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Varone, C.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.2010info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12110/paper_00063363_v83_n1_p42_GambinoBiol. Reprod. 2010;83(1):42-51reponame:Biblioteca Digital (UBA-FCEN)instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesinstacron:UBA-FCENenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/ar2025-09-04T09:48:37Zpaperaa:paper_00063363_v83_n1_p42_GambinoInstitucionalhttps://digital.bl.fcen.uba.ar/Universidad públicaNo correspondehttps://digital.bl.fcen.uba.ar/cgi-bin/oaiserver.cgiana@bl.fcen.uba.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:18962025-09-04 09:48:39.017Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesfalse |
dc.title.none.fl_str_mv |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
title |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
spellingShingle |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions Gambino, Y.P. 17beta-estradiol Gene expression Leptin MAPK signal transduction pathway Placenta 2 (2 amino 3 methoxyphenyl)chromone estradiol estrogen receptor estrogen receptor alpha fulvestrant leptin luciferase mitogen activated protein kinase phosphatidylinositol 3 kinase wortmannin estradiol estrogen receptor alpha estrogen receptor alpha, human fulvestrant leptin mitogen activated protein kinase phosphatidylinositol 3 kinase protein kinase B adipocyte article cancer cell culture choriocarcinoma concentration response controlled study embryo enzyme inhibition enzyme phosphorylation explant gene deletion gene expression human human cell human tissue nidation placenta plasmid pregnancy priority journal promoter region reporter gene signal transduction transient transfection trophoblast Western blotting analogs and derivatives antagonists and inhibitors female in vitro study metabolism placenta signal transduction tumor cell line Bovinae Cell Line, Tumor Estradiol Estrogen Receptor alpha Extracellular Signal-Regulated MAP Kinases Female Humans In Vitro Techniques Leptin MAP Kinase Signaling System Phosphatidylinositol 3-Kinases Placenta Pregnancy Promoter Regions, Genetic Proto-Oncogene Proteins c-akt Receptor Cross-Talk |
title_short |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
title_full |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
title_fullStr |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
title_full_unstemmed |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
title_sort |
17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
dc.creator.none.fl_str_mv |
Gambino, Y.P. Maymó, J.L. Pérez-Pérez, A. Dueñas, J.L. Sánchez-Margalet, V. Calvo, J.C. Varone, C.L. |
author |
Gambino, Y.P. |
author_facet |
Gambino, Y.P. Maymó, J.L. Pérez-Pérez, A. Dueñas, J.L. Sánchez-Margalet, V. Calvo, J.C. Varone, C.L. |
author_role |
author |
author2 |
Maymó, J.L. Pérez-Pérez, A. Dueñas, J.L. Sánchez-Margalet, V. Calvo, J.C. Varone, C.L. |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
17beta-estradiol Gene expression Leptin MAPK signal transduction pathway Placenta 2 (2 amino 3 methoxyphenyl)chromone estradiol estrogen receptor estrogen receptor alpha fulvestrant leptin luciferase mitogen activated protein kinase phosphatidylinositol 3 kinase wortmannin estradiol estrogen receptor alpha estrogen receptor alpha, human fulvestrant leptin mitogen activated protein kinase phosphatidylinositol 3 kinase protein kinase B adipocyte article cancer cell culture choriocarcinoma concentration response controlled study embryo enzyme inhibition enzyme phosphorylation explant gene deletion gene expression human human cell human tissue nidation placenta plasmid pregnancy priority journal promoter region reporter gene signal transduction transient transfection trophoblast Western blotting analogs and derivatives antagonists and inhibitors female in vitro study metabolism placenta signal transduction tumor cell line Bovinae Cell Line, Tumor Estradiol Estrogen Receptor alpha Extracellular Signal-Regulated MAP Kinases Female Humans In Vitro Techniques Leptin MAP Kinase Signaling System Phosphatidylinositol 3-Kinases Placenta Pregnancy Promoter Regions, Genetic Proto-Oncogene Proteins c-akt Receptor Cross-Talk |
topic |
17beta-estradiol Gene expression Leptin MAPK signal transduction pathway Placenta 2 (2 amino 3 methoxyphenyl)chromone estradiol estrogen receptor estrogen receptor alpha fulvestrant leptin luciferase mitogen activated protein kinase phosphatidylinositol 3 kinase wortmannin estradiol estrogen receptor alpha estrogen receptor alpha, human fulvestrant leptin mitogen activated protein kinase phosphatidylinositol 3 kinase protein kinase B adipocyte article cancer cell culture choriocarcinoma concentration response controlled study embryo enzyme inhibition enzyme phosphorylation explant gene deletion gene expression human human cell human tissue nidation placenta plasmid pregnancy priority journal promoter region reporter gene signal transduction transient transfection trophoblast Western blotting analogs and derivatives antagonists and inhibitors female in vitro study metabolism placenta signal transduction tumor cell line Bovinae Cell Line, Tumor Estradiol Estrogen Receptor alpha Extracellular Signal-Regulated MAP Kinases Female Humans In Vitro Techniques Leptin MAP Kinase Signaling System Phosphatidylinositol 3-Kinases Placenta Pregnancy Promoter Regions, Genetic Proto-Oncogene Proteins c-akt Receptor Cross-Talk |
dc.description.none.fl_txt_mv |
The process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc. Fil:Gambino, Y.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Maymó, J.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Varone, C.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. |
description |
The process of embryo implantation and trophoblast invasion is considered the most limiting factor in the establishment of pregnancy. Leptin was originally described as an adipocyte-derived signaling molecule for the central control of metabolism. However, it has been suggested that leptin is involved in other functions during pregnancy, particularly in the placenta, where it was found to be expressed. In the present work, we have found a stimulatory effect of 17beta-estradiol (E2) on endogenous leptin expression, as analyzed by Western blot, in both the BeWo choriocarcinoma cell line and normal placental explants. This effect was time and dose dependent. Maximal effect was achieved at 10 nM in BeWo cells and 1 nM in placental explants. The E 2 effects involved the estrogen receptor, as the antagonist ICI 182 780 inhibited E2-induced leptin expression. Moreover, E2 treatment enhanced leptin promoter activity up to 4-fold, as evaluated by transient transfection with a plasmid construction containing the leptin promoter region and the reporter gene luciferase. This effect was dose dependent. Deletion analysis demonstrated that a minimal promoter region between - 1951 and -1847 bp is both necessary and sufficient to achieve E2 effects. Estradiol action involved estrogen receptor 1, previously known as estrogen receptor alpha, as cotransfection with a vector encoding estrogen receptor 1 potentiated the effects of E2 on leptin expression. Moreover, E2 action probably involves membrane receptors too, as treatment with an estradiol-bovine serum albumin complex partially enhanced leptin expression. The effects of E2 could be blocked by pharmacologic inhibition of MAPK and the phosphoinositide-3-kinase (PI3K) pathways with 50 μM PD98059 and 0.1 μM Wortmannin, respectively. Moreover, cotransfection of dominant negative mutants of MAP2K or MAPK blocked E 2 induction of leptin promoter. On the other hand, E2 treatment promoted MAPK1/MAPK3 and AKT phosphorylation in placental cells. In conclusion, we provide evidence suggesting that E2 induces leptin expression in trophoblastic cells, probably through genomic and nongenomic actions via crosstalk between estrogen receptor 1 and MAPK and PI3K signal transduction pathways. © 2010 by the Society for the Study of Reproduction, Inc. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12110/paper_00063363_v83_n1_p42_Gambino |
url |
http://hdl.handle.net/20.500.12110/paper_00063363_v83_n1_p42_Gambino |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/2.5/ar |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
Biol. Reprod. 2010;83(1):42-51 reponame:Biblioteca Digital (UBA-FCEN) instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales instacron:UBA-FCEN |
reponame_str |
Biblioteca Digital (UBA-FCEN) |
collection |
Biblioteca Digital (UBA-FCEN) |
instname_str |
Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales |
instacron_str |
UBA-FCEN |
institution |
UBA-FCEN |
repository.name.fl_str_mv |
Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales |
repository.mail.fl_str_mv |
ana@bl.fcen.uba.ar |
_version_ |
1842340704913719296 |
score |
12.623145 |